Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
LiveRamp
RAMP
$2.29B
| $77.7M | 0.04% |
2,251,094
+44,808
| +2% | +$1.65M |
|
302
DexCom
DXCM
$29B
| $77.6M | 0.04% |
559,518
-14,999
| -3% | -$1.89M |
|
303
Tesla
TSLA
$1.18T
| $77.4M | 0.04% |
440,360
-415,903
| -49% | -$81.3M |
|
304
Hartford Financial Services
HIG
$39.9B
| $77.4M | 0.04% |
750,982
-162,574
| -18% | -$14.9M |
|
305
CGI
GIB
$15.6B
| $77.4M | 0.04% |
699,798
+681,747
| +3,777% | +$76.3M |
|
306
Waste Management
WM
$95B
| $77.4M | 0.04% |
362,987
-19,257
| -5% | -$3.78M |
|
307
CDW
CDW
$18.9B
| $77.2M | 0.04% |
301,957
+11,861
| +4% | +$2.82M |
|
308
GATX Corp
GATX
$6.45B
| $76.8M | 0.04% |
573,266
-2,423
| -0.4% | -$305K |
|
309
Sabra Healthcare REIT
SBRA
$5.56B
| $76.7M | 0.04% |
5,199,682
+145,548
| +3% | +$2.02M |
|
310
Dyne Therapeutics
DYN
$4.15B
| $75.9M | 0.04% |
2,675,240
+2,663,910
| +23,512% | +$60.2M |
|
311
GE HealthCare
GEHC
$32.7B
| $75.8M | 0.04% |
834,278
+89,400
| +12% | +$7.44M |
|
312
Surgery Partners
SGRY
$2.15B
| $74.7M | 0.04% |
2,504,248
+2,473,282
| +7,987% | +$77.4M |
|
313
Innospec
IOSP
$2.09B
| $74.6M | 0.04% |
578,958
-2,095
| -0.4% | -$254K |
|
314
Janux Therapeutics
JANX
$912M
| $74M | 0.04% |
1,965,546
+34,069
| +2% | +$742K |
|
315
Ligand Pharmaceuticals
LGND
$5.77B
| $73.7M | 0.04% |
1,008,477
-334,677
| -25% | -$24.7M |
|
316
Telus
TU
$17.4B
| $73.3M | 0.04% |
4,572,032
-11,547
| -0.3% | -$202K |
|
317
Universal Display
OLED
$3.75B
| $73.1M | 0.04% |
434,029
+173,496
| +67% | +$30.2M |
|
318
Stride
LRN
$4.16B
| $72.8M | 0.04% |
1,154,995
+30,854
| +3% | +$1.86M |
|
319
CACI
CACI
$10.8B
| $71.5M | 0.04% |
188,696
+178,033
| +1,670% | +$63.3M |
|
320
Zai Lab
ZLAB
$2.07B
| $70.9M | 0.04% |
4,428,011
+387,729
| +10% | +$8.17M |
|
|
321
United Parcel Service
UPS
$88.9B
| $70.6M | 0.04% |
474,854
-3,078,398
| -87% | -$468M |
|
|
ENV
322
DELISTED
ENVESTNET, INC.
ENV
| $70.5M | 0.04% |
1,216,927
-104,554
| -8% | -$5.46M |
|
323
Rocket Pharmaceuticals
RCKT
$343M
| $70.2M | 0.04% |
2,606,016
+1,656,111
| +174% | +$47M |
|
324
Bio-Techne
TECH
$11.2B
| $70.1M | 0.04% |
995,824
+12,991
| +1% | +$930K |
|
325
Mobileye
MBLY
$2.02B
| $69.6M | 0.04% |
+2,166,709
| New | +$61.5M |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.